Clinical Trial Update: Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD) [NA]

View source ↗

Summary

A pilot trial evaluating reduced-fluence photodynamic therapy with Visudyne plus ranibizumab versus ranibizumab alone for exudative age-related macular degenera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: Lahey Clinic | Conditions: Macular Edema | NA | Status: WITHDRAWN